Meeting of the Immunization Strategic Advisory Group of Experts, November 2007--conclusions and recommendations.
D001210:Asia, Southeastern / Q000453:epidemiology; D002648:Child; D005060:Europe / Q000453:epidemiology; D006284:Health Plan Implementation; D006291:Health Policy; D006292:Health Priorities; D006801:Humans; D007114:Immunization; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000600:supply & distribution / Q000627:therapeutic use; D022242:Pneumococcal Vaccines / Q000627:therapeutic use; D011819:Rabies Vaccines / Q000627:therapeutic use; D014436:Typhoid-Paratyphoid Vaccines / Q000627:therapeutic use; D014612:Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D014944:World Health Organization / Q000458:organization & administration
D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D011819:Rabies Vaccines; D014436:Typhoid-Paratyphoid Vaccines; D014612:Vaccines